vs

Side-by-side financial comparison of ASTROTECH Corp (ASTC) and EyePoint, Inc. (EYPT). Click either name above to swap in a different company.

EyePoint, Inc. is the larger business by last-quarter revenue ($619.0K vs $148.0K, roughly 4.2× ASTROTECH Corp). ASTROTECH Corp runs the higher net margin — -2653.4% vs -10922.3%, a 8268.9% gap on every dollar of revenue. On growth, ASTROTECH Corp posted the faster year-over-year revenue change (-43.3% vs -94.7%). ASTROTECH Corp produced more free cash flow last quarter ($-4.0M vs $-66.0M). Over the past eight quarters, ASTROTECH Corp's revenue compounded faster (72.0% CAGR vs -77.0%).

Astrotech Corporation, formerly Spacehab Inc., is a technology incubator headquartered in Austin, Texas. Astrotech uses technology sourced internally and from research institutions, government laboratories, and universities to fund, manage and sell start-up companies. Astrotech Corporation's subsidiaries provide commercial products and services to NASA, the U.S. Department of Defense, national space agencies, and global commercial customers.

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.

ASTC vs EYPT — Head-to-Head

Bigger by revenue
EYPT
EYPT
4.2× larger
EYPT
$619.0K
$148.0K
ASTC
Growing faster (revenue YoY)
ASTC
ASTC
+51.4% gap
ASTC
-43.3%
-94.7%
EYPT
Higher net margin
ASTC
ASTC
8268.9% more per $
ASTC
-2653.4%
-10922.3%
EYPT
More free cash flow
ASTC
ASTC
$62.1M more FCF
ASTC
$-4.0M
$-66.0M
EYPT
Faster 2-yr revenue CAGR
ASTC
ASTC
Annualised
ASTC
72.0%
-77.0%
EYPT

Income Statement — Q2 2026 vs Q4 2025

Metric
ASTC
ASTC
EYPT
EYPT
Revenue
$148.0K
$619.0K
Net Profit
$-3.9M
$-67.6M
Gross Margin
5.4%
Operating Margin
-2635.8%
-11364.3%
Net Margin
-2653.4%
-10922.3%
Revenue YoY
-43.3%
-94.7%
Net Profit YoY
2.0%
-63.3%
EPS (diluted)
$-0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTC
ASTC
EYPT
EYPT
Q4 25
$148.0K
$619.0K
Q3 25
$297.0K
$966.0K
Q2 25
$220.0K
$5.3M
Q1 25
$534.0K
$24.5M
Q4 24
$261.0K
$11.6M
Q3 24
$34.0K
$10.5M
Q2 24
$74.0K
$9.5M
Q1 24
$50.0K
$11.7M
Net Profit
ASTC
ASTC
EYPT
EYPT
Q4 25
$-3.9M
$-67.6M
Q3 25
$-3.5M
$-59.7M
Q2 25
$-2.9M
$-59.4M
Q1 25
$-3.6M
$-45.2M
Q4 24
$-4.0M
$-41.4M
Q3 24
$-3.3M
$-29.4M
Q2 24
$-3.0M
$-30.8M
Q1 24
$-3.2M
$-29.3M
Gross Margin
ASTC
ASTC
EYPT
EYPT
Q4 25
5.4%
Q3 25
63.3%
Q2 25
33.6%
Q1 25
44.4%
Q4 24
59.4%
Q3 24
26.5%
93.0%
Q2 24
37.8%
85.2%
Q1 24
16.0%
93.5%
Operating Margin
ASTC
ASTC
EYPT
EYPT
Q4 25
-2635.8%
-11364.3%
Q3 25
-1190.6%
-6420.8%
Q2 25
-1326.4%
-1166.8%
Q1 25
-724.2%
-199.7%
Q4 24
-1655.6%
-390.4%
Q3 24
-10670.6%
-311.2%
Q2 24
-4518.9%
-364.5%
Q1 24
-7066.0%
-285.2%
Net Margin
ASTC
ASTC
EYPT
EYPT
Q4 25
-2653.4%
-10922.3%
Q3 25
-1166.7%
-6183.4%
Q2 25
-1331.8%
-1114.3%
Q1 25
-680.3%
-184.8%
Q4 24
-1536.0%
-357.3%
Q3 24
-9641.2%
-279.0%
Q2 24
-3998.6%
-325.3%
Q1 24
-6308.0%
-250.6%
EPS (diluted)
ASTC
ASTC
EYPT
EYPT
Q4 25
$-0.82
Q3 25
$-0.85
Q2 25
$-0.85
Q1 25
$-0.65
Q4 24
$-0.65
Q3 24
$-0.54
Q2 24
$-0.58
Q1 24
$-0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTC
ASTC
EYPT
EYPT
Cash + ST InvestmentsLiquidity on hand
$7.0M
$306.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$15.5M
$306.1M
Total Assets
$19.7M
$364.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTC
ASTC
EYPT
EYPT
Q4 25
$7.0M
$306.1M
Q3 25
$11.3M
$204.0M
Q2 25
$15.1M
$255.7M
Q1 25
$18.1M
$318.2M
Q4 24
$21.5M
$370.9M
Q3 24
$21.8M
$253.8M
Q2 24
$42.9M
$280.2M
Q1 24
$52.4M
$299.3M
Stockholders' Equity
ASTC
ASTC
EYPT
EYPT
Q4 25
$15.5M
$306.1M
Q3 25
$19.1M
$200.2M
Q2 25
$22.1M
$246.0M
Q1 25
$24.8M
$298.4M
Q4 24
$28.1M
$336.5M
Q3 24
$32.1M
$218.7M
Q2 24
$34.8M
$228.3M
Q1 24
$37.6M
$249.9M
Total Assets
ASTC
ASTC
EYPT
EYPT
Q4 25
$19.7M
$364.0M
Q3 25
$23.2M
$251.7M
Q2 25
$27.0M
$301.1M
Q1 25
$27.5M
$362.6M
Q4 24
$31.0M
$418.5M
Q3 24
$34.4M
$300.9M
Q2 24
$37.6M
$324.2M
Q1 24
$40.2M
$329.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTC
ASTC
EYPT
EYPT
Operating Cash FlowLast quarter
$-3.5M
$-65.0M
Free Cash FlowOCF − Capex
$-4.0M
$-66.0M
FCF MarginFCF / Revenue
-2671.6%
-10667.7%
Capex IntensityCapex / Revenue
277.7%
159.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.9M
$-243.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTC
ASTC
EYPT
EYPT
Q4 25
$-3.5M
$-65.0M
Q3 25
$-3.9M
$-59.4M
Q2 25
$-2.4M
$-62.6M
Q1 25
$-3.9M
$-53.1M
Q4 24
$-3.0M
$-35.8M
Q3 24
$-3.7M
$-39.0M
Q2 24
$-2.5M
$-20.2M
Q1 24
$-2.3M
$-31.2M
Free Cash Flow
ASTC
ASTC
EYPT
EYPT
Q4 25
$-4.0M
$-66.0M
Q3 25
$-4.4M
$-60.2M
Q2 25
$-2.7M
$-63.8M
Q1 25
$-3.9M
$-53.4M
Q4 24
$-3.4M
$-36.2M
Q3 24
$-3.9M
$-40.6M
Q2 24
$-2.8M
$-21.1M
Q1 24
$-2.5M
$-32.4M
FCF Margin
ASTC
ASTC
EYPT
EYPT
Q4 25
-2671.6%
-10667.7%
Q3 25
-1476.1%
-6226.9%
Q2 25
-1231.4%
-1196.5%
Q1 25
-728.1%
-218.4%
Q4 24
-1288.5%
-312.7%
Q3 24
-11408.8%
-385.8%
Q2 24
-3728.4%
-222.4%
Q1 24
-5036.0%
-277.0%
Capex Intensity
ASTC
ASTC
EYPT
EYPT
Q4 25
277.7%
159.3%
Q3 25
150.8%
82.6%
Q2 25
158.2%
22.9%
Q1 25
5.1%
1.1%
Q4 24
122.2%
3.3%
Q3 24
567.6%
15.0%
Q2 24
305.4%
9.5%
Q1 24
352.0%
10.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons